HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Amelioration of cisplatin-induced mouse renal lesions by a cyclooxygenase (COX)-2 selective inhibitor.

Abstract
In this study, we investigated the effects of the cyclooxygenase (COX)-2 selective inhibitor, meloxicam, on cisplatin-induced inflammation, oxidative stress and renal lesions in BALB/c mice. A single cisplatin injection (13 mg/kg, i.p.) significantly increased plasma creatinine, blood urea nitrogen and urinary glucose accompanied by a concomitant increase in COX-2 mRNA and COX-2 protein levels. These changes in renal lesion parameters were diminished by simultaneous treatment of meloxicam (0.7 mg/kg/day in drinking water). The expression of oxidative stress markers, p47(phox), p67(phox), hemoxygenase-1 (HO-1), nicotinamide adenine dinucleotide phosphate (NADPH) oxidase 2 (NOX2) and 4-hydroxy-2-nonenal (4-HNE)-modified protein were increased with cisplatin injection. Simultaneous treatment of meloxicam with cisplatin significantly inhibited the increase in p47(phox), HO-1 and 4-HNE-modified protein. The phosphorylation of extracellular regulated kinase (ERK) and c-jun-N-terminal kinase (JNK) were increased with cisplatin injection, but these changes were inhibited by meloxicam. Moreover, concomitant meloxicam treatment also prevented the cisplatin-induced infiltration of macrophages to the tubulointerstitial area. These results suggest that meloxicam can ameliorate cisplatin-induced mouse renal lesions, potentially through the inhibition of inflammatory and oxidative stress responses.
AuthorsShigeyoshi Honma, Naho Takahashi, Masahiro Shinohara, Kazuki Nakamura, Satoru Mitazaki, Sumiko Abe, Makoto Yoshida
JournalEuropean journal of pharmacology (Eur J Pharmacol) Vol. 715 Issue 1-3 Pg. 181-8 (Sep 05 2013) ISSN: 1879-0712 [Electronic] Netherlands
PMID23747596 (Publication Type: Journal Article)
Copyright© 2013 Elsevier B.V. All rights reserved.
Chemical References
  • Cyclooxygenase 2 Inhibitors
  • Thiazines
  • Thiazoles
  • Thromboxane B2
  • Cyclooxygenase 2
  • Dinoprostone
  • Cisplatin
  • Meloxicam
Topics
  • Animals
  • Cisplatin (adverse effects)
  • Cyclooxygenase 2 (genetics, metabolism)
  • Cyclooxygenase 2 Inhibitors (pharmacology)
  • Dinoprostone (urine)
  • Gene Expression Regulation, Enzymologic (drug effects)
  • Kidney (drug effects)
  • Macrophages (drug effects, immunology)
  • Male
  • Meloxicam
  • Mice
  • Mice, Inbred BALB C
  • Oxidative Stress (drug effects)
  • Thiazines (pharmacology)
  • Thiazoles (pharmacology)
  • Thromboxane B2 (urine)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: